$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The real experience of taking ribociclib/ribociclib for two consecutive years
2026-02-01 22:25:32
Check Details
Is cimepilimab an imported drug or a domestic drug?
2026-02-01 22:25:32
Check Details
Which company is the manufacturer of daprostat?
2026-02-01 22:25:32
Check Details
How long does durvalumab infusion usually take?
2026-02-01 22:25:32
Check Details
Estimated total cost of lifelong treatment with margetuximab
2026-02-01 22:25:32
Check Details
What are the possible reasons why there is no improvement after taking Avonib for three years?
2026-02-01 22:25:32
Check Details
Erlotinib belongs to several generations of targeted drugs. What are its characteristics?
2026-02-01 22:25:32
Check Details
Can tofacitinib tablets effectively treat white spots (vitiligo)?
2026-02-01 22:25:32
Check Details
How long does a standard treatment cycle of cycloserine take?
2026-02-01 22:25:32
Check Details
Linezolid injection uses and methods of administration
2026-02-01 22:25:32
Check Details
Is ribociclib/ribociclib a chemotherapy drug or a targeted drug?
2026-02-01 22:25:32
Check Details
Cimepilimab price per injection and treatment cost
2026-02-01 22:25:32
Check Details
1
2
...
1504
1505
1506
1507
1508
1509
1510
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Filgotinib: Mechanism of Action and Clinical Applications Explained
4
Lapatinib: Proper Administration Guide and Key Precautions
5
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
6
Cemiplimab Storage and Handling Guide
7
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
8
FDA Approves First mRNA Flu Vaccine mFLUSIVA
9
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
10
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring